Delayed wound healing is one of the most common secondary adverse effects associated to the therapeutic use of glucocorticoid (GC) analogs, which act through the ligand-dependent transcription factor GC-receptor (GR). GR function is exerted through DNA-binding-dependent and –independent mechanisms, classically referred to as transactivation (TA) and transrepression (TR). Currently both TA and TR are thought to contribute to the therapeutical effects mediated by GR; however their relative contribution to unwanted side effects such as delayed wound healing is unknown. We evaluated skin wound healing in transgenic mice with keratinocyte-restricted expression of either wild type GR or a mutant GR that is TA-defective but efficient in TR (K5-GR and K5-GR-TR mice, respectively). Our data show that at days (d) 4 and 8 following wounding, healing in K5-GR mice was delayed relative to WT, with reduced recruitment of granulocytes and macrophages and diminished TNF-α and IL-1β expression. TGF-β1 and Kgf expression was repressed in K5-GR skin whereas TGF-β3 was up-regulated. The re-epithelialization rate was reduced in K5-GR relative to WT, as was formation of granulation tissue. In contrast, K5-GR-TR mice showed delays in healing at d4 but re-established the skin breach at d8 concomitant with decreased repression of pro-inflammatory cytokines and growth factors relative to K5-GR mice. Keratinocytes from both transgenic mice closed in vitro wounds slower relative to WT, consistent with the in vivo defects in cell migration. Overall, the delay in the early stages of wound healing in both transgenic models is similar to that elicited by systemic treatment with dexamethasone. Wound responses in the transgenic keratinocytes correlated with reduced ERK activity both in vivo and in vitro. We conclude that the TR function of GR is sufficient for negatively regulating early stages of wound closure, while TA by GR is required for delaying later stages of healing.
References
[1]
De Bosscher K, Haegeman G (2009) Minireview: Latest Perspectives on Antiinflammatory Actions of glucocorticoids. Mol Endocrinol 23: 281–291.
[2]
Sch？cke H, D？cke WD, Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96: 23–43.
[3]
Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905–1917.
[4]
Revollo JR, Cidlowski JA (2009) Mechanisms Generating Diversity in glucocorticoid Receptor Signaling. Ann NY Acad Sci 1179: 167–178.
[5]
Stanisi？ V, Lonard DM, O'Malley BW (2010) Modulation of steroid hormone receptor activity. Prog Brain Res 181: 153–176.
[6]
So A, Cooper SB, Feldman BJ, Manuchehri M, Yamamoto KR (2008) Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc Natl Acad Sci USA 105: 5745–5749.
[7]
Kassel O, Herrlich P (2007) Cross-talk between the glucocorticoid receptor and other transcription factors:molecular aspects. Mol Cell Endocrinol 275: 13–29.
[8]
Davies L, Karthikeyan N, Lynch JT, Sial E, Gkourtsa A, Demonacos C, Krstic-Demonacos M (2009) Cross Talk of Signaling Pathways in the Regulation of the glucocorticoid Receptor Function. Mol Endocrinol 22: 1331–1344.
[9]
Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531–541.
[10]
Cole TJ, Blendy AP, Monaghan K, Schmid W, Aguzzi A, et al. (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9: 1608–1621.
[11]
Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99–103.
[12]
Helmberg A, Auphan N, Caelles C, Karin M (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14(3): 452–460.
[13]
Clark A (2007) Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 275: 79–97.
[14]
Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, et al. (2007) Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117: 1381–1390.
[15]
Werner S, Grose R (2003) Regulation of Wound Healing by Growth Factors and Cytokines. Physiol Rev 83: 835–870.
[16]
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Rep Reg 16: 585–601.
[17]
Beer HD, Fassler R, Werner S (2000) Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitamins and hormones 59: 217–239.
[18]
Pérez P, Page A, Bravo A, Del Río M, Gimenez-Conti I, et al. (2001) Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor. FASEB J 15: 2030–2032.
[19]
Donet E, Bosch P, Sanchis A, Bayo P, Ramírez A, et al. (2008) Transrepression function of the glucocorticoid receptor regulates eyelid development and keratinocyte proliferation but is not sufficient to prevent skin chronic inflammation. Mol Endocrinol 22: 799–812.
[20]
Lai JJ, Lai KP, Chuang KH, Chang P (2009) Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression. J Clin Invest 119(12): 3739–3751.
[21]
Bayo P, Sanchis A, Bravo A, Cascallana JL, Buder K, et al. (2008) Glucocorticoid receptor is required for skin barrier competence. Endocrinology 149: 1377–1388.
[22]
Sanchis A, Bayo P, Sevilla L, Pérez P (2010) Glucocorticoid receptor antagonizes EGFR function to regulate eyelid development. International J Dev Biol 54(10): 1473–1480.
[23]
Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, et al. (2005) The role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167: 59–69.
[24]
Choi EH, Demerjian M, Crumrine D, Brown BE, Mauro T, et al. (2005) Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. FASEB J 19: 1332–1334.
[25]
Cascallana JL, Bravo A, Donet E, Leis H, Lara MF, et al. (2005) Ectoderm-Targeted Overexpression of the glucocorticoid Receptor Induces Hypohidrotic Ectodermal Dysplasia. Endocrinology 146: 2629–2638.
[26]
Slominski A, Wortsman J, Paus R, Elias PM, Tobin DJ, et al. (2008) Skin as an endocrine organ:implications for its function. Drug Discov Today Dis Mech 5: 137–144.
[27]
Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, et al. (2011) Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem.
[28]
Grose R, Werner S, Kessler D, Tuckermann J, Huggel K, et al. (2002) A role for endogenous glucocorticoids in wound repair. EMB rep 3(6): 575–582.
[29]
Lee B, Vouthounis C, Stojadinovic O, Brem H, Im M, et al. (2005) From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing. J Mol Biol 345: 1083–1097.
[30]
Ramot Y, Paus R, Tiede S, Zlotogorski A (2009) Endocrine controls of keratin expression Bio Essays 31: 389–399.
[31]
Radoja N, Komine M, Jho SH, Blumenberg M, Tomic-Canic M (2000) Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol 2000 20: 4328–433.
[32]
Takayama S, Rogatsky I, Schwarcz LE, Darimont BD (2006) The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex. J Biol Chem 281(26): 17856–17863.
[33]
Turchi L, Chassot AA, Rezzonico R, Yeow K, Loubat A, et al. (2002) Dynamic Characterization of the Molecular Events During In Vitro Epidermal Wound Healing. J Invest Dermatol 119: 56–63.
[34]
Yemelyanov A, Czwornog J, Chebotaev D, Karseladze A, Kulevitch E, et al. (2007) Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 26(13): 1885–1896.
[35]
De Bosscher K (2010) Selective glucocorticoid receptor modulators. J Steroid Biochem Mol Biology 120: 96–104.
[36]
Komi-Kuramochi A, Kawano M, Oda Y, Asada M, Suzuki M, et al. (2005) Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J Endocrinol 186(2): 273–289.
